🔗 Share this article

Texas Attorney General Paxton is taking legal action against the manufacturers of acetaminophen, alleging the firms concealed alleged dangers that the drug posed to children's brain development.

The lawsuit arrives thirty days after Former President Trump advocated an unproven link between taking Tylenol - alternatively called acetaminophen - while pregnant and autism in children.

Paxton is taking legal action against J&J, which previously sold the drug, the only pain reliever approved for expectant mothers, and Kenvue, which currently produces it.

In a statement, he claimed they "misled consumers by making money from discomfort and promoting medication without regard for the risks."

The manufacturer asserts there is no credible evidence connecting acetaminophen to autism.

"These companies misled for generations, deliberately risking numerous people to line their pockets," the attorney general, from the Republican party, declared.

Kenvue commented that it was "seriously troubled by the dissemination of inaccurate information on the reliability of paracetamol and the potential impact that could have on the well-being of women and children in America."

On its official site, Kenvue also said it had "consistently assessed the pertinent research and there is insufficient valid information that shows a verified association between using paracetamol and autism."

Associations acting on behalf of physicians and health professionals share this view.

The leading OB-GYN organization has stated acetaminophen - the primary component in Tylenol - is one of the few options for women during pregnancy to address pain and elevated temperature, which can create major wellness concerns if left untreated.

"In multiple decades of investigation on the utilization of acetaminophen in pregnancy, not a single reputable study has definitively established that the usage of paracetamol in any trimester of gestation causes neurodevelopmental disorders in young ones," the organization commented.

The court filing references latest statements from the Trump administration in arguing the medication is reportedly hazardous.

In recent weeks, the former president generated worry from health experts when he instructed expectant mothers to "fight like hell" not to consume acetaminophen when ill.

The US Food and Drug Administration then published an announcement that doctors should contemplate reducing the use of Tylenol, while also declaring that "a causal relationship" between the medication and autism spectrum disorder in young ones has not been established.

Health Secretary RFK Jr, who supervises the Food and Drug Administration, had pledged in April to conduct "extensive scientific investigation" that would establish the cause of autism in a matter of months.

But experts warned that identifying a sole reason of autism spectrum disorder - thought by researchers to be the outcome of a intricate combination of genetic and external influences - would prove challenging.

Autism is a category of enduring cognitive variation and impairment that influences how persons encounter and relate to the environment, and is identified using medical professional evaluations.

In his legal document, the attorney general - aligned with the former president who is seeking US Senate - alleges Kenvue and J&J "willfully ignored and attempted to silence the research" around acetaminophen and autism spectrum disorder.

The case attempts to require the corporations "remove any promotional materials" that asserts acetaminophen is safe for expectant mothers.

The Texas lawsuit mirrors the concerns of a group of mothers and fathers of young ones with autism spectrum disorder and attention deficit hyperactivity disorder who filed suit against the producers of acetaminophen in recently.

The court threw out the case, declaring investigations from the parents' expert witnesses was lacking definitive proof.